By Mill Chart
Last update: Aug 22, 2023
In this article we will dive into IRADIMED CORP (NASDAQ:IRMD) as a possible candidate for quality investing. Investors should always do their own research, but we noticed IRADIMED CORP showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.
ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.
Overall IRMD gets a fundamental rating of 7 out of 10. We evaluated IRMD against 205 industry peers in the Health Care Equipment & Supplies industry. IRMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IRMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make IRMD suitable for growth and quality investing!
For an up to date full fundamental analysis you can check the fundamental report of IRMD
More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
IRADIMED CORP
NASDAQ:IRMD (4/22/2024, 7:08:51 PM)
After market: 42.36 0 (0%)42.36
+1.36 (+3.32%)
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference...
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP...
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth...
A Relative Strength Rating upgrade for Bruker stock shows improving technical performance. Will it continue?
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the...